The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infectionsThomas Tängdén, Jason A. Roberts, Véronique Martin et al.|Intensive Care Medicine|2017Cited by 149
Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutationsLuc Deroche, Julien M. Buyck, Albane Rozenholc et al.|International Journal of Infectious Diseases|2024Cited by 14
Characterization of <i>Pseudomonas aeruginosa</i> resistance to ceftolozane-tazobactam due to <i>ampC</i> and/or <i>ampD</i> mutations observed during treatment using semi-mechanistic PKPD modelingLuc Deroche, Julien M. Buyck, Vincent Aranzana‐Climent et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 6
<i>In vitro</i> pharmacokinetic/pharmacodynamic modeling of the effect of mucin on polymyxin B activity against <i>Acinetobacter baumannii</i>Mathilde Lacroix, Alexia Chauzy, Jérémy Moreau et al.|Antimicrobial Agents and Chemotherapy|2025Cited by 3